Search

everythinglearnresearchcommunity

for

Search:↓

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Androgens play a key role in causing alopecia by changing the hair growth cycle.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

COVID-19 can worsen upper gastrointestinal bleeding, requiring quick and varied treatments.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Many people in Thailand have lingering symptoms after recovering from COVID-19.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Estrogen may help improve COVID-19 outcomes, especially in women.

During COVID-19, Iraqi women saw more hair loss and skin issues like acne due to stress, masks, and hygiene habits.

During COVID-19, Iraqi women experienced more hair loss and skin issues like acne, likely due to stress and mask-wearing.

Testosterone's effects on COVID-19 are unclear and need more research.

Some drugs may help treat both COVID-19 and radiation injury.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.